This article has been updated from a previous version, which miscalculated the company's R&D spending.
NEW YORK (GenomeWeb News) — Clinical Data’s fiscal third-quarter revenues increased 20 percent as R&D spending rose by nearly 80 percent and net losses decreased 580 percent, according to preliminary earnings report.
Total receipts for the three months ended Dec. 31, 2006, increased to $22 million from $18.4 million year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.